The Journal of Molecular Diagnostics Media Room
News from The Journal of Molecular Diagnostics
The Journal of Molecular Diagnostics (JMD), co-published by the Association for Molecular Pathology (AMP) and the American Society for Investigative Pathology (ASIP), publishes high quality original papers on scientific advances in the translation and validation of molecular discoveries in medicine into the clinical diagnostic setting, and the description and application of technological advances in the field of molecular diagnostic medicine.
Embargo Policy
When a manuscript is accepted for publication in JMD, it is under embargo and not for public release until publication. Articles are typically embargoed until 12:01 AM ET the day of online publication.
Authors are permitted to present their research prior to publication before peers at scientific meetings, but should refrain from distributing copies of their paper, including data tables and figures.
All press releases are under embargo until the covered article becomes available becomes available in electronic form (in advance of print publication). We will provide the media with full-text copies of the articles in question prior to the embargo date so that coverage can be adequately researched and written.
Embargo Policy for Articles in Press
Some articles accepted for publication will first appear online under Articles In Press. This section contains peer reviewed accepted articles to be published in JMD. When the final article is assigned to an issue of JMD, the Article In Press version will be removed from this section and will appear with the table of contents for the monthly published journal issue. The date it was first made available online will be carried over.
There are three types of Articles In Press:
- Accepted manuscripts: Articles that have been peer reviewed and accepted for publication by the Editorial Board. The articles have not yet been copy edited and/or formatted.
- Uncorrected proofs: Copy edited and formatted articles that are not yet finalized and that will be corrected by the authors.
- Corrected proofs: Articles containing the authors' corrections.
All studies published in JMD are embargoed until published online as a corrected proof. Studies cannot be publicized as accepted manuscripts or uncorrected proofs.
Conditions
- Embargo dates and times must accompany all advanced materials (typically, 12:01 AM ET on the date of online publication). Embargoed information is not to be made public in any format, including print, television, radio, or via the Internet, before the embargo.
- Advanced material is for background research only. However, reporters may share embargoed papers with experts in the field for the purpose of obtaining relevant commentary. Embargoed materials must be clearly labeled with the embargo date and time. Journalists are responsible for ensuring that all third parties honor the embargo date.
- Journalists should credit JMD as the source of information. Articles published in the journal reflect original, independent, peer-reviewed research. While Elsevier is the publisher of JMD, articles appearing in the journal do not necessarily reflect the views or policies of the organization unless stated as such.
- Failure to adhere to this policy will result in denial of access to embargoed material from JMD and Elsevier.
The press releases are in PDF format. To view these, Adobe Acrobat 6.01 or later is recommended.
Press Services and Contact Information
2012 Press Releases
List of press release titles + dates, and links to text for articles
New Virtual Tool May Provide More Accurate Diagnosis of Genetic Mutations
New technology described in The Journal of Molecular Diagnostics
February 6, 2012
2011 Press Releases
New Protocols Improve Detection of MicroRNAs for Diagnosis
Reported in a New Study in The Journal of Molecular Diagnostics
December 7, 2011
Improved Method for Detecting Mutant DNAs
Reported in a New Study in The Journal of Molecular Diagnostics
October 11, 2011
2010 Press Releases
New Diagnostic Test for Bladder Cancer (July 2010)
Rapid Prenatal Test for alpha-Thalassemia (May 2010)
Personalized Medicine in Warfarin Therapy (March 2010)
Rapid Flu Testing (January 2010)
Timothy O'Leary Named Next Editor-in-Chief of The Journal of Molecular Diagnostics
Press Services and Contact Information
Please contact us to:
- Inquire about specific articles published in The Journal of Molecular Diagnostics
- Request full text of articles published in The Journal of Molecular Diagnostics
- Help arrange author interviews
- Verify an embargo date
- Add your name to the JMD press mailing list
- Inquire about The Journal of Molecular Diagnostics in general
Eileen Leahy
Tel: +1 732 238 3628
Fax: +1 732 613 8860
JMDmedia@elsevier.com
